Jammi Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 3.50 M
as on 06-07-2024
- Paid Up Capital ₹ 3.15 M
as on 06-07-2024
- Company Age 6 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 8.05 M
as on 06-07-2024
- Revenue 43.14%
(FY 2023)
- Profit 56.00%
(FY 2023)
- Ebitda 81.09%
(FY 2023)
- Net Worth 4.50%
(FY 2023)
- Total Assets 54.56%
(FY 2023)
About Jammi Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 3.50 M and a paid-up capital of Rs 3.15 M.
The company currently has active open charges totaling ₹8.05 M.
Anitha Balachander, Jammi Narasu, and Jammi Narasimham serve as directors at the Company.
- CIN/LLPIN
U85310TN2018PTC122433
- Company No.
122433
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
02 May 2018
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Chennai, Tamil Nadu, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Jammi Pharmaceuticals Private Limited offer?
Jammi Pharmaceuticals Private Limited offers a wide range of products and services, including Ayurveda Cosmetics, Herbal Foot Cream, Ayur, Herbal Diabetes Syrup, Herbal Acne Cream.
Who are the key members and board of directors at Jammi Pharmaceuticals?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jammi Narasimham  | Director | 02-May-2018 | Current |
| Anitha Balachander | Additional Director | 07-Jul-2021 | Current |
| Jammi Narasu | Director | 02-May-2018 | Current |
Financial Performance and Corporate Structure Insights of Jammi Pharmaceuticals.
Jammi Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 43.14% increase. The company also saw a substantial improvement in profitability, with a 56% increase in profit. The company's net worth moved up by a moderate rise of 4.5%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Jammi Pharmaceuticals?
In 2023, Jammi Pharmaceuticals had a promoter holding of 79.61% and a public holding of 20.39%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Kriscore Jammi Wellness Private LimitedActive 8 months 5 daysAnitha Balachander and Jammi Narasimham are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 10 Aug 2022 | ₹8.05 M | Open |
How Many Employees Work at Jammi Pharmaceuticals?
Jammi Pharmaceuticals has a workforce of 42 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Jammi Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Jammi Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
